Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Sep;41(9):2057–2058. doi: 10.1128/aac.41.9.2057

Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.

C L Kelley 1, D A Rouse 1, S L Morris 1
PMCID: PMC164068  PMID: 9303417

Abstract

The ahpC genes of 57 clinical isolates and one in vitro mutant of Mycobacterium tuberculosis were evaluated by nucleotide sequence analyses. Although compensatory ahpC promoter mutations were identified in 8 catalase-negative, katG-defective strains, the ahpC genes of 25 catalase-positive, isoniazid-resistant isolates and 25 drug-sensitive strains were not altered.

Full Text

The Full Text of this article is available as a PDF (169.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee A., Dubnau E., Quemard A., Balasubramanian V., Um K. S., Wilson T., Collins D., de Lisle G., Jacobs W. R., Jr inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994 Jan 14;263(5144):227–230. doi: 10.1126/science.8284673. [DOI] [PubMed] [Google Scholar]
  2. Dhandayuthapani S., Zhang Y., Mudd M. H., Deretic V. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. J Bacteriol. 1996 Jun;178(12):3641–3649. doi: 10.1128/jb.178.12.3641-3649.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Heym B., Alzari P. M., Honoré N., Cole S. T. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol. 1995 Jan;15(2):235–245. doi: 10.1111/j.1365-2958.1995.tb02238.x. [DOI] [PubMed] [Google Scholar]
  4. Heym B., Stavropoulos E., Honoré N., Domenech P., Saint-Joanis B., Wilson T. M., Collins D. M., Colston M. J., Cole S. T. Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect Immun. 1997 Apr;65(4):1395–1401. doi: 10.1128/iai.65.4.1395-1401.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Johnsson K., Froland W. A., Schultz P. G. Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. J Biol Chem. 1997 Jan 31;272(5):2834–2840. doi: 10.1074/jbc.272.5.2834. [DOI] [PubMed] [Google Scholar]
  6. Morris S., Bai G. H., Suffys P., Portillo-Gomez L., Fairchok M., Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis. 1995 Apr;171(4):954–960. doi: 10.1093/infdis/171.4.954. [DOI] [PubMed] [Google Scholar]
  7. Musser J. M., Kapur V., Williams D. L., Kreiswirth B. N., van Soolingen D., van Embden J. D. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis. 1996 Jan;173(1):196–202. doi: 10.1093/infdis/173.1.196. [DOI] [PubMed] [Google Scholar]
  8. Rouse D. A., DeVito J. A., Li Z., Byer H., Morris S. L. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microbiol. 1996 Nov;22(3):583–592. doi: 10.1046/j.1365-2958.1996.00133.x. [DOI] [PubMed] [Google Scholar]
  9. Rouse D. A., Li Z., Bai G. H., Morris S. L. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1995 Nov;39(11):2472–2477. doi: 10.1128/aac.39.11.2472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sherman D. R., Mdluli K., Hickey M. J., Arain T. M., Morris S. L., Barry C. E., 3rd, Stover C. K. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science. 1996 Jun 14;272(5268):1641–1643. doi: 10.1126/science.272.5268.1641. [DOI] [PubMed] [Google Scholar]
  11. Sherman D. R., Sabo P. J., Hickey M. J., Arain T. M., Mahairas G. G., Yuan Y., Barry C. E., 3rd, Stover C. K. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6625–6629. doi: 10.1073/pnas.92.14.6625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sreevatsan S., Pan X., Zhang Y., Deretic V., Musser J. M. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother. 1997 Mar;41(3):600–606. doi: 10.1128/aac.41.3.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tai S. S., Zhu Y. Y. Cloning of a Corynebacterium diphtheriae iron-repressible gene that shares sequence homology with the AhpC subunit of alkyl hydroperoxide reductase of Salmonella typhimurium. J Bacteriol. 1995 Jun;177(12):3512–3517. doi: 10.1128/jb.177.12.3512-3517.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wilson T. M., Collins D. M. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol Microbiol. 1996 Mar;19(5):1025–1034. doi: 10.1046/j.1365-2958.1996.449980.x. [DOI] [PubMed] [Google Scholar]
  15. Zhang Y., Dhandayuthapani S., Deretic V. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13212–13216. doi: 10.1073/pnas.93.23.13212. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES